From stealthy polymersomes and filomicelles to "self" peptide-nanoparticles for cancer therapy

Annual Review of Chemical and Biomolecular Engineering

Volumn 5, Issue , 2014, Pages 281-299

  Oltra, Núria Sancho ^a   Nair, Praful ^a   Discher, Dennis E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Degradable block copolymer; Drug delivery; Stealthiness; Vesicle; Wormlike micelle

Indexed keywords

BLOCK COPOLYMERS; DRUG DELIVERY; DRUG DOSAGE; NANOPARTICLES; ONCOLOGY; PEPTIDES; POLYETHYLENE GLYCOLS; DISEASES;

ANIMAL MODELS OF CANCER; COMBINATION THERAPY; DEGRADABLE BLOCK COPOLYMER; POLYMER COMPOSITION; SPECIFIC INTERACTION; STEALTHINESS; VESICLE; WORM-LIKE MICELLES;

POLYMERS;

ANTINEOPLASTIC AGENT; NANOPARTICLE; PACLITAXEL; PEPTIDE; POLYMER;

CHEMISTRY; DEGRADABLE BLOCK COPOLYMER; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METHODOLOGY; MICELLE; NEOPLASM; PATHOLOGY; REVIEW; STEALTHINESS; TUMOR VOLUME; VESICLE; WORMLIKE MICELLE;

DEGRADABLE BLOCK COPOLYMER; DRUG DELIVERY; STEALTHINESS; VESICLE; WORMLIKE MICELLE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG DELIVERY SYSTEMS; HUMANS; MICELLES; NANOPARTICLES; NEOPLASMS; PACLITAXEL; PEPTIDES; POLYMERS; TUMOR BURDEN;

EID: 84902485956     PISSN: 19475438     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev-chembioeng-060713-040447     Document Type: Review

References (80)

1. Bangham AD, Standish MM, Watkins JC. 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13:238-52
2. Gregoriadis G, Ryman BE. 1971. Liposomes as carriers of enzymes or drugs: A new approach to the treatment of storage diseases. Biochem. J. 124:58P
3. Mayhew E, Papahadjopoulos D, Rustum YM, Dave C. 1976. Inhibition of tumor cell growth in vitro and in vivo by 1-β-D-Arabinofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res. 36:4406-11
4. Juliano RL, Stamp D. 1978. Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin. Biochem. Pharmacol. 27:21-27
5. Immordino ML, Dosio F, Cattel L. 2006. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomedicine 1:297-315
6. Park JW. 2002. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res. 4:95-99
7. Discher DE, Eisenberg A. 2002. Polymer vesicles. Science 297:967-73
8. Brinkhuis RP, Rutjes FPJT, van Hest JCM. 2011. Polymeric vesicles in biomedical applications. Polym. Chem. 2:1449-62
9. Blanazs A, Armes SP, Ryan AJ. 2009. Self-Assembled block copolymer aggregates: frommicelles to vesicles and their biological applications. Macromol. Rapid Commun. 30:267-77
10. Kataoka K, Harada A, Nagasaki Y. 2012. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 64:37-48
11. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, et al. 2007. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2:249-55
12. Vriezema DM, Garcia PML, Sancho Oltra N, Hatzakis NS, Kuiper SM, et al. 2007. Positional assembly of enzymes in polymersome nanoreactors for cascade reactions. Angew. Chem. Int. Ed. 46:7378-82
13. Wilson JT,Keller S,Manganiello MJ,Cheng C, LeeC-C, et al. 2013. pH-responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. ACS Nano 7:3912-25
14. Christian DA, Cai S, Garbuzenko OB, Harada T, Zajac AL, et al. 2009. Flexible filaments for in vivo imaging and delivery: Persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Mol. Pharm. 6:1343-52
15. Sancho Oltra N, Swift J, Mahmud A, Rajagopal K, Loverde SM, Discher DE. 2013. Filomicelles in nanomedicine-from flexible, fragmentable, and ligand-targetable drug carrier designs to combination therapy for brain tumors. J. Mater. Chem. B 1:5177-85
16. Nair LS, Laurencin CT. 2006. Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv. Biochem. Eng./Biotechnol. 102:47-90
17. Yang Y, Pan D, Luo K, Li L, Gu Z. 2013. Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Biomaterials 34:8430-43
18. Zhang Y, Chan HF, Leong KW. 2013. Advanced materials and processing for drug delivery: the past and the future. Adv. Drug Deliv. Rev. 65:104-20
19. Seyednejad H, Ghassemi AH, van Nostrum CF, Vermonden T, Hennik WE. 2011. Functional aliphatic polyesters for biomedical and pharmaceutical applications. J. Control. Release 152:168-76
20. Dash TK, Konkimalla VB. 2012. Poly-∈-caprolactone based formulations for drug delivery and tissue engineering: A review. J. Control. Release 158:15-33
21. Albertsson A-C, Ljungquist O. 1986. Degradable polymers. I. Synthesis, characterization, and long-term in vitro degradation of a 14C-labeled aliphatic polyester. J. Macromol. Sci. A Pure Appl. Chem. 23:393-409
22. Albertsson A-C, Ljungquist O. 1986. Degradable polymers. II. Synthesis, characterization, and degradation of an aliphatic thermoplastic block copolyester. J. Macromol. Sci. A Pure Appl. Chem. 23:411-22
23. Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, et al. 2004. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew. Chem. Int. Ed. 43:6323-27
24. Liu L, Zheng M, Renette T, Kissel T. 2012. Modular synthesis of folate conjugated ternary copolymers: polyethylenimine-graft-polycaprolactone-block- poly(ethylene glycol)-folate for targeted gene delivery. Bioconjugate Chem. 23:1211-20
25. Letchford K, Burt H. 2007. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 65:259-69
26. Rajagopal K, Mahmud A, Christian DA, Pajerowski JD, Brown AEX, et al. 2010. Curvature-coupled hydration of semicrystalline polymer amphiphiles yields flexible worm micelles but favors rigid vesicles: polycaprolactone-based block copolymers. Macromolecules 43:9736-46
27. Kita-Tokarczyk K, Grumelard J, Haefele T, Meier W. 2005. Block copolymer vesicles-using concepts from polymer chemistry to mimic biomembranes. Polymer 46:3540-63
28. Rajagopal K, Christian DA, Harada T, Tian A, Discher DE. 2010. Polymersomes and wormlike micelles made fluorescent by direct modifications of block copolymer amphiphiles. Int. J. Polym. Sci. 2010:379286
29. Danino D. 2012. Cryo-TEM of soft molecular assemblies. Curr. Opin. Colloid Interface Sci. 17:316-29
30. Liaw J, Aoyagi T, Kataoka K, Sakurai Y, Okano T. 1998. Visualization of PEO-PBLA-pyrene polymeric micelles by atomic force microscopy. Pharm. Res. 15:1721-26
31. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 65:271-84
32. Greenwald RB, Gilbert CW, Pendri A, Conover CD, Xia J, Martinez A. 1996. Drug delivery systems: water soluble taxol 2-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. J. Med. Chem. 39:424-31
33. Yang B-B, Lum PK,HayashiMM,Roskos LK. 2004. Polyethylene glycol modification of filgrastim results in decreased renal clearance of the protein in rats. J. Pharm. Sci. 93:1367-73
34. Schreiber S. 2011. Certolizumab pegol for the treatment of Crohn's disease. Ther. Adv. Gastroenterol. 4:375-89
35. Klibanov AL, Maruyama K, Torchilin VP, Huang L. 1990. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235-37
36. Garay RP, Labaune JP. 2011. Immunogenicity of polyethylene glycol (PEG). Open Conf. Proc. J. 2:104-7
37. Ichihara M, Shimizu T, Imoto A, Hashiguchi Y, Uehara Y, et al. 2011. Anti-PEG IgM response against PEGylated liposomes in mice and rats. Pharmaceutics 3:1-11
38. Brown L, McArthur SL, Wright PC, Lewis A, Battaglia G. 2010. Polymersome production on amicrofluidic platform using pH sensitive block copolymers. Lab Chip 10:1922-28
39. Murdoch C, Reeves KJ, Hearnden V, Colley H, Massignani M, et al. 2010. Internalization and biodistribution of polymersomes into oral squamous cell carcinoma cells in vitro and in vivo. Nanomedicine 5:1025-36
40. Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE. 2013. Minimal "self " peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339:971-75
41. Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. 2011. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. USA 108:10980-85
42. Severi E, Hood DW, Thomas GH. 2007. Sialic acid utilization by bacterial pathogens. Microbiology 153:2817-22
43. Constantinou A, Epenetos AA, Hreczuk-Hirst D, Jain S, Deonarain MP. 2008. Modulation of antibody pharmacokinetics by chemical polysialylation. Bioconjugate Chem. 19:643-50
44. Muro S, GarnachoC,Champion JA, Leferovich J, Gajewski C, et al. 2008. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther. 16:1450-58
45. Pangburn TO, Georgiou K, Bates FS, Kokkoli E. 2012. Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression. Langmuir 28:12816-30
46. Lin JJ, Ghoroghchian PP, Zhang Y, Hammer DA. 2006. Adhesion of antibody-functionalized polymersomes. Langmuir 22:3975-79
47. Kim B-S, Yang W-Y, Ryu J-H, Yoo Y-S, Lee M. 2005. Carbohydrate-coated nanocapsules from amphiphilic rod-coil molecule: binding to bacterial type 1 pili. Chem. Commun. 15:2035-37
48. Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, et al. 2010. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. ACS Nano 4:6805-17
49. Broz P, Benito SM, Saw CL, Burger P, Heider H, et al. 2005. Cell targeting by a generic receptor-targeted polymer nanocontainer platform. J. Control. Release 102:475-88
50. Diamandis EP, Christopoulos TK. 1991. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin. Chem. 37:625-36
51. Rigler P, Meier W. 2006. Encapsulation of fluorescent molecules by functionalized polymeric nanocontainers: investigation by confocal fluorescence imaging and fluorescence correlation spectroscopy. J. Am. Chem. Soc. 128:367-73
52. Dalhaimer P, Engler AJ, Parthasarathy R, Discher DE. 2004. Targeted worm micelles. Biomacromolecules 5:1714-19
53. Shuvaev VV, Ilies MA, Simone E, Zaitsev S, Kim Y, et al. 2011. Endothelial targeting of antibodydecorated polymeric filomicelles. ACS Nano 5:6991-99
54. Nehring R, Palivan CG, Moreno-Flores S, Mantion A, Tanner P, et al. 2010. Protein decorated membranes by specific molecular interactions. Soft Matter 6:2815-24
55. Felici M, Marza-Perez M, Hatzakis NS, Nolte RJM, Feiters MC. 2008. β-Cyclodextrin-Appended giant amphiphile: aggregation to vesicle polymersomes and immobilisation of enzymes. Chem. Eur. J. 14:9914-20
56. Opsteen JA, Brinkhuis RP, Teeuwen RLM, L owik DWPM, van Hest JCM. 2007. "Clickable" polymersomes. Chem. Commun. 30:3136-38
57. Pang Z, Lu W, Gao H,Hu K,Chen J, et al. 2008. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J. Control. Release 128:120-27
58. van Dongen SFM, Verdurmen WPR, Peters RJRW, Nolte RJM, Brock R, van Hest JCM. 2010. Cellular integration of an enzyme-loaded polymersome nanoreactor. Angew. Chem. Int. Ed. 49:7213-16
59. Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE. 2006. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J. Control. Release 116:150-58
60. Geng Y, Discher DE. 2006. Visualization of degradable worm micelle breakdown in relation to drug release. Polymer 47:2519-25
61. Geng Y, Discher D. 2005. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J. Am. Chem. Soc. 127:12780-81
62. Loverde SM, Ortiz V, Kamien RD, Klein ML, Discher DE. 2010. Curvature-driven molecular demixing in the budding and breakup of mixed component worm-like micelles. Soft Matter 6:1419-25
63. Jeong IK, GaoGH, Li Y, Kang SW, Lee DS. 2013. A biodegradable polymersome with pH-tuning on-off membrane based on poly(β-Amino ester) for drug delivery. Macromol. Biosci. 13:946-53
64. Yan Q, Wang J, Yin Y, Yuan J. 2013. Breathing polymersomes: CO2-tuning membrane permeability for size-selective release, separation, and reaction. Angew. Chem. Int. Ed. 52:5070-73
65. Sanson C, Schatz C, Le Meins J-F, Soum A, Thevenot J, et al. 2010. A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J. Control. Release 147:428-35
66. Napoli A, Valentini M, Tirelli N, Muller M, Hubbell JA. 2004. Oxidation-responsive polymeric vesicles. Nat. Mater. 3:183-89
67. Xu H, Meng F, Zhong Z. 2009. Reversibly crosslinked temperature- responsive nano-sized polymersomes: synthesis and triggered drug release. J. Mater. Chem. 19:4183-90
68. Cerritelli S, Velluto D, Hubbell JA. 2007. PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules 8:1966-72
69. Dan K, Pan R, Ghosh S. 2011. Aggregation and pH responsive disassembly of a new acid-labile surfactant synthesized by thiol-Acrylate Michael addition reaction. Langmuir 27:612-17
70. Cabane E, Malinova V,Menon S, Palivan CG, Meier W. 2011. Photoresponsive polymersomes as smart, triggerable nanocarriers. Soft Matter 7:9167-76
71. Cheng R, Meng F, Deng C, Klok H-A, Zhong Z. 2013. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34:3647-57
72. Mayer LD, Bally MB, Cullis PR. 1986. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim. Biophys. Acta 857:123-26
73. Upadhyay KK, Bhatt AN, Castro E, Mishra AK, Chuttani K, et al. 2010. In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes. Macromol. Biosci. 10:503-12
74. Ayen WY, Kumar N. 2012. In vivo evaluation of doxorubicin-loaded (PEG)3-PLA nanopolymersomes (PolyDoxSome) using DMBA-induced mammary carcinoma rat model and comparison with marketed LipoDoxTM. Pharm. Res. 29:2522-33
75. Song N, Liu W, Tu Q, Liu R, Zhang Y, Wang J. 2011. Preparation and in vitro properties of redoxresponsive polymeric nanoparticles for paclitaxel delivery. Colloids Surf. B 87:454-63
76. Meng F, Zhong Z, Feijen J. 2009. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 10:197-209
77. Hu C-MJ, Aryal S, Zhang L. 2010. Nanoparticle-Assisted combination therapies for effective cancer treatment. Ther. Deliv. 1:323-34
78. Kim H-O, Kim E, An Y, Choi J, Jang E, et al. 2013. A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect. Macromol. Biosci. 13:745-54
79. Pang Z, Feng L, Hua R, Chen J, Gao H, et al. 2010. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Mol. Pharm. 7:1995-2005
80. Baumann BC, Kao GD, Mahmud A, Harada T, Swift J, et al. 2013. Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy. Oncotarget 4:64-79